menu
    • menu

    Company profile for Monopar Therapeutics

    NEW Drugs in Dev: 10
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Monopar Therapeutics is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to improve clinical outcomes for cancer patients. The Company's pipeline consists of Validive® for the potential prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin for the potential treatment of advanced soft tissue sarcoma; and a late-stage precli...
    Monopar Therapeutics is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to improve clinical outcomes for cancer patients. The Company's pipeline consists of Validive® for the potential prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin for the potential treatment of advanced soft tissue sarcoma; and a late-stage preclinical antibody MNPR-101. For more information visit: www.monopartx.com.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Monopar TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1000 Skokie Blvd. Suite 350 Wilmette, IL 60091
    Telephone
    Telephone
    (847) 388-0349
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.monopartx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Monopar Reveals ALXN1840 Outperforms SoC In Wilson Disease
    Monopar Reveals ALXN1840 Outperforms SoC In Wilson Disease

    19 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/19/3276675/0/en/monopar-presents-phase-3-data-showing-greater-neurologic-benefit-with-alxn1840-vs-soc-in-wilson-disease-patients-with-neurologic-symptoms-at-aan-2026.html

    GLOBENEWSWIRE
    19 Apr 2026
    Share Share
    Monopar Reports 2025 Financial Results And Business Update
    Monopar Reports 2025 Financial Results And Business Update

    27 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/27/3263989/0/en/Monopar-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    27 Mar 2026
    Share Share
    Monopar Appoints Rodriguez Chief Commercial and Strategy Officer
    Monopar Appoints Rodriguez Chief Commercial and Strategy Officer

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247341/0/en/Monopar-Expands-Leadership-Team-with-Appointment-of-Seasoned-Biopharma-Executive-Susan-Rodriguez-as-Chief-Commercial-and-Strategy-Officer.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    Monopar Therapeutics Reveals Q3 2025 Financials And Updates
    Monopar Therapeutics Reveals Q3 2025 Financials And Updates

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187279/0/en/Monopar-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Developments.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Monopar Reveals Enhanced Copper Balance In Wilson Disease
    Monopar Reveals Enhanced Copper Balance In Wilson Disease

    09 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/09/3184138/0/en/Monopar-Presents-New-Data-and-Analyses-on-Rapidly-Improved-Copper-Balance-in-Wilson-Disease-Patients-on-Tiomolybdate-Choline-at-AASLD-The-Liver-Meeting-2025.html

    GLOBENEWSWIRE
    09 Nov 2025
    Share Share
    Monopar To Present Abstract Orally At AASLD Liver Meeting 2025
    Monopar To Present Abstract Orally At AASLD Liver Meeting 2025

    15 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/15/3167014/0/en/Monopar-Announces-Abstract-Accepted-for-Oral-Presentation-at-AASLD-The-Liver-Meeting-2025.html

    GLOBENEWSWIRE
    15 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search